Two different jobs
Written from FDA prescribing information, DailyMed labeling and current gastroparesis guidance. See the full source list.
The medicines used for gastroparesis fall into two big groups that do very different jobs. Mixing them up is one of the most common sources of confusion — and it changes how you judge whether something is "working."
Movers vs. soothers
A prokinetic actually tries to fix the problem — it nudges a sluggish stomach to empty faster. An antiemetic does something else entirely — it quiets the nausea, but the stomach still empties just as slowly as before.
Picture a kitchen sink draining slowly. A prokinetic is like clearing the drain so the water finally goes down. It works on the actual problem — the slow emptying itself.
Nausea is like an alarm going off. An antiemetic switches the alarm off, which is a real relief. But the alarm was only the signal — turning it off doesn't speed the stomach up, so the slow emptying is still there underneath.
See the difference
Turn each medicine on and watch what changes. Notice that "ease the nausea" calms the meter without changing how the stomach empties.
Why this matters for the wider family
Gastroparesis is the main event here, but it lives in a family of motility problems sometimes called digestive tract paralysis. Some of the medicines on the next pages actually target further downstream — the intestines and colon — rather than the stomach. We'll flag those clearly so it's obvious what's for gastroparesis and what's for a related condition.
Getting things moving
These are the "movers" — medicines meant to help a slow stomach empty. Only one is actually FDA-approved specifically for gastroparesis; the others are borrowed from elsewhere and used off-label.
Reglan (metoclopramide) Prokinetic FDA-approved for GP
- What it is
- The only medicine FDA-approved specifically for gastroparesis in the US. It both speeds emptying and calms nausea, which is unusual.
- How you take it
- By mouth as a tablet, dissolving tablet, or liquid, usually before meals. A nasal spray (Gimoti), FDA-approved in 2020 for adults with diabetic gastroparesis, is an option when vomiting makes pills hard to keep down. Also available as an injection in hospital.
- What it does
- Blocks dopamine to make the stomach contract more strongly and empty faster, while also quieting the brain's nausea center.
- Common effects
- Drowsiness, restlessness, fatigue; sometimes anxiety or low mood.
- Warnings
- Can cause extrapyramidal movement effects. Your doctor sets the dose based on your kidney function, age, and other medicines.
Long-term use can cause tardive dyskinesia, a movement disorder that may be permanent and has no known treatment. It's uncommon — but the risk rises the longer you take the drug and the more you take, which is why treatment is generally limited to 12 weeks. This is a safety limit, not a target dose, and it applies to every form, including the nasal spray.
Motegrity (prucalopride) Prokinetic Off-label for GP
- What it is
- Approved for chronic constipation, used off-label for gastroparesis. Evidence in gastroparesis is mixed.
- How you take it
- One tablet by mouth once a day.
- What it does
- Activates serotonin (5-HT4) receptors in the gut to stimulate movement. It's a pure mover — no direct effect on nausea.
- Common effects
- Headache, abdominal pain, nausea, diarrhea, especially early on.
- Warnings
- Prescribing information notes watching for new low mood or thoughts of self-harm. For adults only.
Domperidone (Motilium) Prokinetic Not FDA-approved
- What it is
- Used widely in other countries, but not approved in the US. It works like Reglan but causes fewer brain-related side effects because it mostly stays out of the brain.
- How you get it
- In the US, only through the FDA's Expanded Access program — a strict process for patients 12+ who've failed other treatments. Note: the FDA has said the expanded-access supply was set to end after September 2025, so availability is uncertain.
- What it does
- Blocks dopamine to speed emptying and reduce nausea.
- Common effects
- Generally milder day-to-day effects than Reglan; dry mouth, headache.
- Warnings
- Can affect heart rhythm.
Domperidone can cause QT prolongation and, rarely, sudden cardiac events — the main reason it isn't approved in the US. Risk is higher at higher doses and in people over 60. Use involves ECG and blood monitoring.
Erythromycin (Ery-Tab, E.E.S., EryPed) Prokinetic Off-label for GP
- What it is
- An old antibiotic that, at low doses, happens to be the strongest stomach-emptying stimulant of the group. It's used for the emptying effect, not to fight infection.
- How you take it
- By mouth (often a liquid, to allow small doses) before meals, or by IV in hospital for flare-ups.
- What it does
- Mimics motilin, a hormone that triggers strong stomach contractions.
- Common effects
- Cramping, nausea, abdominal pain.
- Warnings
- Can affect heart rhythm (QT prolongation) and interacts with many other drugs. Long-term use risks antibiotic resistance.
Erythromycin is like a spring that loses its bounce with constant pressing — the body gets used to it and it stops working as well (called tachyphylaxis). Doctors often work around this with "drug holidays," using it in short stretches rather than continuously.
Linzess (linaclotide) Downstream — the colon
- What it is
- The odd one out. Linzess isn't a stomach mover or a nausea soother — it works lower down, in the intestines and colon, for constipation-type conditions like colonic inertia. It belongs to the wider motility family, not gastroparesis itself.
- How you take it
- One capsule by mouth once a day, on an empty stomach.
- What it does
- A secretagogue — it pulls fluid into the gut to get things moving through the lower digestive tract.
- Common effects
- Diarrhea is the most common, and can be severe.
- Warnings
- Not for people with a suspected bowel blockage.
Linzess is never for children under 2 — in the very young it can cause life-threatening dehydration.
Easing the nausea
These are the "soothers." They don't speed up emptying — they turn down the nausea and vomiting so day-to-day life is more livable. They're often used alongside a mover.
Zofran (ondansetron) Antiemetic
- What it is
- A widely used anti-nausea medicine. The Zofran brand is largely gone from US pharmacies; the generic ondansetron is what's usually dispensed.
- How you take it
- Tablet, dissolving tablet, liquid, or IV.
- What it does
- Blocks serotonin (5-HT3) receptors that trigger the vomiting reflex. It does not change how fast the stomach empties.
- Common effects
- Headache, fatigue, and — worth noting for this community — constipation, which can be a real problem when your gut is already sluggish.
- Warnings
- Can cause QT prolongation (heart-rhythm changes), especially at high IV doses — the 32 mg IV dose was pulled for this reason. Rarely, it contributes to serotonin syndrome when combined with other serotonin drugs.
Meclizine (Antivert, Bonine) Antiemetic
- What it is
- An antihistamine best known for motion sickness and vertigo. It plays a smaller, more occasional role in gastroparesis, for the dizziness-and-queasiness type of nausea.
- How you take it
- Tablet or chewable by mouth.
- What it does
- Blocks histamine (and has an anticholinergic effect) to settle the balance-and-nausea pathways.
- Common effects
- Drowsiness, dry mouth, blurred vision.
- Warnings
- Its anticholinergic effect can slow the gut further and is used cautiously in older adults.
Promethazine (Phenergan) Antiemetic
- What it is
- A strong, sedating anti-nausea medicine used when milder options aren't enough.
- How you take it
- Tablet, liquid, rectal suppository, or injection.
- What it does
- Blocks histamine and dopamine signals involved in nausea and vomiting.
- Common effects
- Marked drowsiness, dry mouth; sometimes restlessness or movement effects.
- Warnings
- Can be strongly sedating, especially when you first start — for many people this eases over the first days as the body adjusts. Take extra care with driving early on, and with combining it with alcohol or other sedatives.
1. Never for children under 2 — it can cause fatal breathing suppression. 2. Given as an injection, it can cause severe tissue and blood-vessel injury, including gangrene — the danger is greatest if it leaks out of the vein or enters an artery.
Prochlorperazine (Compro; UK: Stemetil, Buccastem) Antiemetic
- What it is
- A long-established medicine for severe nausea and vomiting, from the same chemical family as promethazine. Current gastroparesis guidance lists it among the standard anti-nausea options. In the US it's mostly dispensed as a generic; Compazine and Procomp are older brand names you may still hear.
- How you take it
- Tablet, rectal suppository (Compro), or injection. In the UK it also comes as a buccal tablet (Buccastem is one brand; generic versions are also sold) that dissolves against the gum under the upper lip instead of being swallowed — useful when pills won't stay down.
- What it does
- Blocks dopamine signals in the brain's vomiting center. It does not change how fast the stomach empties.
- Common effects
- Drowsiness, dizziness, blurred vision; sometimes restlessness.
- Warnings
- Because it blocks dopamine, it can cause the same extrapyramidal movement effects as Reglan, and with long-term use, tardive dyskinesia. Tell your doctor if you also take Reglan, since both block dopamine. Rarely it causes neuroleptic malignant syndrome — high fever, rigid muscles, and confusion — which is an emergency.
In older adults with dementia-related psychosis, drugs in this class raise the risk of death. Prochlorperazine is not approved for that use.
Glossary
Plain-language definitions for the terms used throughout this guide.
About this guide
Written in plain language from the primary sources below — mainly US FDA prescribing information and the FDA's own domperidone pages, plus current gastroparesis management guidance. It describes what medicines do and what to watch for; it does not give doses, because the right dose depends entirely on the individual and is set by a physician. Last reviewed October 2026.
Sources
- Metoclopramide (Reglan) — boxed warning for tardive dyskinesia and the 12-week limit: FDA prescribing information.
- Metoclopramide nasal spray (Gimoti) — approved for adults with diabetic gastroparesis, same tardive dyskinesia boxed warning: FDA prescribing information; its place alongside oral metoclopramide: AGA guideline, 2025 (below).
- Promethazine — boxed warnings for respiratory depression in children under 2 and severe tissue injury with injection: FDA-approved labeling via DailyMed; NEJM summary of the pediatric warning.
- Prochlorperazine — boxed warning for increased mortality in elderly patients with dementia-related psychosis; tardive dyskinesia and neuroleptic malignant syndrome warnings; dosage forms: FDA-approved labeling via DailyMed. UK buccal tablet, how it is placed: Prochlorperazine maleate 3 mg Buccal Tablets (POM), Summary of Product Characteristics (eMC; a generic product record). Its place among anti-nausea options in gastroparesis: AGA guideline, 2025 (below).
- Linaclotide (Linzess) — boxed warning, contraindicated under age 2 (serious dehydration); mechanism and common effects: DailyMed label.
- Ondansetron (Zofran) — QT-prolongation warning and withdrawal of the 32 mg IV dose: FDA-approved labeling via DailyMed. (FDA's 2012 drug safety communication has since been removed from fda.gov; the warning remains in current labeling.)
- Prucalopride (Motegrity) — 5-HT4 agonist, approved for chronic constipation, off-label in gastroparesis: FDA-approved labeling via DailyMed.
- Domperidone — not FDA-approved; Expanded Access (IND) only; cardiac risk; supply notice: FDA: Information about domperidone; FDA: How to request domperidone.
- Erythromycin as a prokinetic, tachyphylaxis and drug holidays; overall drug-selection context: AGA Clinical Practice Guideline on the Management of Gastroparesis, 2025.
Links go to third-party sites (FDA, DailyMed, NEJM, and clinical guidance) and were current at the time of writing. Prescribing information is updated periodically; your pharmacist or physician has the most current version.